- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06707454
Postoperative Clinical and Neurophysiological Assessment of Patients After Open Heart Surgery
Study Overview
Status
Intervention / Treatment
Detailed Description
Coronary artery bypass grafting (CABAG) is one of the most common major surgical procedures, as more than 800,000 patients worldwide undergo myocardial revascularization procedures every year. Cardiopulmonary bypass (CPB) is an extracorporeal circulation procedure that assists the operation of cardiac and great vessels and is associated with perioperative morbidity and mortality.
Preoperative neurophysiological status as measured by electroencephalogram (EEG) had a specificity of 94.7% and a sensitivity of 76.9% for predicting 1-week postoperative cognitive status and with specificity of 78.3% and a sensitivity of 77.8% for predicting 3-months postoperative cognitive status.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Osama A Ebrahim, Master
- Phone Number: 00201016386372
- Email: osamaallam@med.asu.edu.eg
Study Locations
-
-
-
Cairo, Egypt, 11591
- Recruiting
- Ain Shams University
-
Contact:
- Osama A Ebrahim, Master
- Phone Number: 00201016386372
- Email: osamaallam@med.asu.edu.eg
-
Sub-Investigator:
- Mahmoud H EL Rakawy, MD
-
Sub-Investigator:
- Naglaa M EL Khayat, MD
-
Sub-Investigator:
- Ahmed A Gaber, MD
-
Sub-Investigator:
- Yousry A Abdelhamid, MD
-
Sub-Investigator:
- Adel M ELansary, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient ≥ 60 years.
- Both sexes.
- Patients who are scheduled for on-pump open heart surgery either isolated coronary artery bypass grafting (CABG) or combined CABG and valve surgery.
Exclusion Criteria:
- Patients with a past history of CNS disease (e.g. Epilepsy, brain tumors, or Dementia).
- Patients with metabolic disturbance.
- Illiterate patient.
- Patient with sever cognitive impairment on Mini-mental state Examination (MMSE) and/or Montreal Cognitive Assessment (MoCA)
- Patients who cannot undergo DEEG recordings (eg, uncooperative).
- Patients with abnormal brain images except for small vessel disease.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study group
Patients who will undergo open heart surgery, such as isolated coronary artery bypass grafting (CABG) or combined CABG and valve surgery.
|
The enrolled patients will undergo Digital Electroencephalography (DEEG) monitoring for at least two hours.
A senior epileptologist will make a DEEG interpretation to detect DEEG abnormality.
DEEG patterns will be categorized according to the American Clinical Neurophysiology Society's standardized critical care DEEG terminology(normal, slowing and asymmetry, sharp and wave, periodic discharges, ictal patterns burst suppression, and electrocerebral silence)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neurological complications
Time Frame: 4 months postoperatively
|
Neurological complications, including nonconvulsive seizures after open heart surgery, will be recorded.
|
4 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Electroencephalography (DEEG) monitoring
Time Frame: 24 hours postoperatively
|
The enrolled patients will undergo Digital Electroencephalography (DEEG) monitoring for at least two hours.
A senior epileptologist will interpret the DEEG to detect abnormalities.
The DEEG patterns will be categorized according to the American Clinical Neurophysiology Society's standardized critical care DEEG terminology(normal, slowing and asymmetry, sharp and wave, periodic discharges, ictal patterns burst suppression, and electrocerebral silence).
|
24 hours postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FMASU MD115/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinical
-
Cairo UniversityNot yet recruiting
-
Hawler Medical UniversityCompletedClinical Performance | Objective Structured Clinical ExaminationIraq
-
Jonsson Comprehensive Cancer CenterNational Institute on Aging (NIA)Not yet recruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage I Esophageal Adenocarcinoma AJCC v8 | Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Esophageal... and other conditionsUnited States
-
University of Social Sciences and Humanities, WarsawWithin PropertiesRecruitingStudy Protocol Feasibility | Non Clinical Anxiety | Non Clinical Worry | Non Clinical RuminationPoland
-
Jonsson Comprehensive Cancer CenterNot yet recruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage II Esophageal... and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingClinical Examination of the Shoulder | Video-assisted Clinical ExaminationFrance
-
University of California, DavisNational Cancer Institute (NCI)SuspendedClinical Stage 0 Cutaneous Melanoma AJCC v8 | Clinical Stage I Cutaneous Melanoma AJCC v8 | Clinical Stage II Cutaneous Melanoma AJCC v8United States
-
Çanakkale Onsekiz Mart UniversityCompletedSocial Support | Clinical Competence | Objective Structured Clinical Examination | Students, Medical | Education, Medical, Undergraduate | Medical Students | Clinical Skills Education | Peer Support InterventionsTurkey (Türkiye)
-
China Medical University HospitalActive, not recruitingMotivation | Clinical Skills Training | Nursing Students | OSCE (Objective Structured Clinical Examination)Taiwan
-
The University of Texas Health Science Center,...CompletedUnderstanding of Consent in Clinical Research | Implementation of Consent in Clinical ResearchUnited States
Clinical Trials on Digital Electroencephalography (DEEG)
-
Assiut UniversityNot yet recruitingEpilepsy | Cognitive ImpairmentEgypt
-
Centre Hospitalier Universitaire de BesanconTerminated
-
Daegu Catholic University Medical CenterCompletedAttention Deficit Hyperactivity Disorder | Psychiatric Diagnosis | Diagnosis, PsychiatricKorea, Republic of
-
Rennes University HospitalCompleted
-
University Hospital, CaenCentre Hospitalier Universitaire de BesanconNot yet recruitingNeurodevelopmental Changes (Childhood, Ageing)
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Parc de Salut MarAelis Farma; StarlabRecruiting
-
Ulrich MehnertNCCR (National Center of Competence in Resaerch, Switzerland)CompletedHealthy | Neurogenic Bladder Dysfunction Nos | Nonneurogenic Neurogenic Bladder DysfunctionSwitzerland
-
Guangzhou Women and Children's Medical CenterBeijing X-Magtech Technology LimitedRecruitingRefractory Epilepsy in ChildrenChina
-
Central Hospital, Nancy, FranceInstitut National de la Santé Et de la Recherche Médicale, France; CHU de Reims and other collaboratorsCompletedPartial EpilepsyFrance